Press releases and news

Select year

No posts found

May 16, 2025

BioGaia ranked among TIME’s 500 best global companies in sustainable growth

BioGaia has been recognized by TIME Magazine´s and Statista’s prestigious list of the World’s Top 500 Companies Pairing Growth with Environmental Stewardship. This recognition highlights BioGaia’s commitment to combining strong business performance with responsible environmental practices. The ranking evaluates 5,000 global companies based on three core dimensions: revenue growth, financial stability, and environmental impact. The […]
Regulatory
May 7, 2025

Annual General Meeting of BioGaia

The Annual General Meeting of BioGaia AB (publ) on 7 May 2025 voted, among other things, to approve the following resolutions: – adoption of the income statement and balance sheet and the consolidated income statement and consolidated balance sheet – discharge from liability for the Board members and the CEO – a dividend of SEK […]
May 7, 2025

BioGaia AB establishes direct sales in the Netherlands

BioGaia AB (NASDAQ: BIOG) is expanding its global footprint by establishing direct sales in the Netherlands initially through an online approach. BioGaia will launch sales of its products on the major local marketplaces, Bol.com and Amazon.nl. This initiative supports BioGaia’s long-term strategy to expand through direct sales and bring its clinically proven probiotics closer to […]
Regulatory
May 7, 2025

BioGaia AB: Interim Management Statement January – March 2025

FIRST QUARTER 2025 Net sales amounted to SEK 366.3 million (369.8), a decrease of SEK 3.5 million, or a decrease of 1% (excluding foreign exchange effects a decrease of 3.6%). Net sales in the Pediatrics segment amounted to SEK 269.9 million (292.3), a decrease of 8% (excluding foreign exchange effects a decrease of 10%). Net […]
April 23, 2025

Invitation to media and analyst briefing for BioGaia Q1 2025 report

BioGaia’s (NASDAQ: BIOG) financial report for the first quarter of 2025 will be published at approximately 8:00 AM CEST on May 7, 2025. The company will issue a press release with the complete financial report attached, including tables. Following publication of the press release, the financial report will be available on BioGaia´s website. CEO Theresa […]
Regulatory
April 2, 2025

Notice to attend the Annual General Meeting of BioGaia AB (publ)

BioGaia AB (publ) will hold its Annual General Meeting at 4 p.m. on 7 May 2025, at Klara Konferens & Happynings på Klara Strand, Klarabergsviadukten 90, in Stockholm. The doors will be opened for registration at 3:30 p.m. Right to participate In order to participate in the Annual General Meeting (AGM), shareholders must be recorded […]
Regulatory
March 26, 2025

BioGaia Annual and Sustainability Report 2024 published

BioGaia´s (NASDAQ: BIOG) Annual and Sustainability Report 2024, including Corporate Governance Report 2024, and the Remuneration Report 2024 in Swedish as well as an English translation are now available to download from the BioGaia website: https://www.biogaiagroup.com/investors/reports-and-presentations/annual-reports The Swedish Annual and Sustainability Report 2024 is also available on BioGaia’s website in European Single Electronic Format (ESEF). […]
Regulatory
March 20, 2025

Transition in BioGaia: Anatom Holding, a Switzerland-based long-term investment firm, becomes anchor shareholder

“I believe this is a very positive next step for BioGaia. For over 35 years, we have been a committed part of BioGaia’s journey, supporting its growth and development. Now, the time has come for a new long-term anchor shareholder to accompany BioGaia into the future. After in-depth discussions with Anatom, we are confident that […]
Regulatory
February 12, 2025

BioGaia AB: Year-end report January – December 2024

FOURTH QUARTER 2024 (Figures in parentheses refer to the corresponding period last year, unless otherwise specified). Net sales amounted to SEK 364.8 million (297.8), an increase of SEK 67.1 million, or 23% (excluding foreign exchange effects an increase of 24%). Net sales in the Pediatrics segment amounted to SEK 270.3 million (220.0), an increase of […]

Subscribe to our press releases

Be the first to know all about the latest news from BioGaia.

Subscribe